BioNTech SE - ADR vs Dollar General Corp. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Dollar General Corp. trades at $120.29 (market cap $26.49B). The key difference: BioNTech SE - ADR and Dollar General Corp. are close in size by market cap, and Dollar General Corp. pays a 1.97% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DG | |
|---|---|---|
Market Cap | $23.31B | $26.49B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $156.26 |
52-Week Low | $83.89 | $95.94 |
Enterprise Value | $6.60B | $40.93B |
Dividend Yield | — | 1.97% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →